Volume 22 (2024): Issue 2.5 (Apr 2024): Abstracts from the NCCN 2024 Annual Conference

in Journal of the National Comprehensive Cancer Network
Online ISSN:
1540-1413
Print ISSN:
1540-1405
Cover Journal of the National Comprehensive Cancer Network
Young Investigator Awards
YIA24-001: Spatial Evolution of Immune Cell Dysfunction During Development of Oligometastatic Renal Cell Carcinoma: Secondary Analysis of a Prospective Trial
YIA24-002: Patients’ Perspectives on Being Treated by Multiple Care Teams for Autologous Transplant/CAR-T Eligible Lymphoma and Multiple Myeloma
YIA24-003: A Phase I Study of TAS102 Plus Talazoparib in Advanced Colorectal (CRC) and Esophagogastric (EGC) Adenocarcinomas
YIA24-004: Liquid Biomarkers of Response to Radium-223 in Metastatic Prostate Cancer
YIA24-005: MAIT Cells are Reduced in Anorectal Mucosal Melanomas Compared to Cutaneous Melanoma GI Metastases
YIA24-006: The NF-I/a Transcription Factor is a HIF-Independent Oncogenic Dependency in Kidney Cancer
YIA24-007: Genetic Ancestry and Genomic Alterations of Cervical Cancer in a Diverse Patient Population
Best Practices in Implementation and Use of Clinical Practice Guidelines
BPI24-008: Pumping Iron in the Preoperative Period: Is It Beneficial in Reducing Blood Transfusions?
BPI24-009: Improving Adherence to Safe Handling of Oral Hazardous Drugs and Contaminated Wastes Guidelines
BPI24-010: Temporary Toilet Lids Minimize Contamination of Bathroom Surfaces With Hazardous Drugs
BPI24-011: Impact of Obesity on Sentinel Lymph Node Mapping in Patients With Endometrial Intraepithelial Neoplasia Undergoing Robotic Surgery
BPI24-012: Comparing Cancer Risk Management Between Females With Truncating CHEK2 1100delC Versus Missense CHEK2 I157T Variants
BPI24-013: Microwave Ablation Versus Resection Versus Stereotactic Body Radiation Therapy of Stage IA Non–Small Cell Lung Cancer in US Veterans
BPI24-014: Implementation of Therapeutic Touch in an Ambulatory Palliative Oncology Clinic
BPI24-015: Reporting the False Negative Rate of Sentinel Lymph Node Biopsy for Melanoma SLNB: A Useful Quality Control Metric
BPI24-016: Clinical Behavior, Oncological Outcomes, and External Validation of the Gronchi Nomogram in Patients Diagnosed With Primary Retroperitoneal Sarcoma Treated at a Latin American Reference Center Between 2009–2018
BPI24-017: Optimizing the Implementation of New Therapies in Multiple Myeloma
BPI24-018: Quality Recommendations for the Management of Cutaneous Squamous Cell Carcinoma (CSCC)
BPI24-019: Estimation of Impact of Care Gap on Patient Outcome and Health Care Cost Burden Using Real World Data in Early-Stage NSCLC—An Empirical Study for Delay in Surgery
BPI24-020: Institutional Policy Implementation for Allocating Chemotherapy During a Shortage
BPI24-021: Impact of Social Determinants (SDOH) on Surgery and Patient Outcomes in Early-Stage Non–Small Cell Lung Cancer (eNSCLC)
BPI24-022: Our Approach to Patient Selection for Polatuzumab-Based Therapy in Advanced Diffuse Large B-Cell Lymphoma
BPI24-023: Empirical Study to Estimate Real World Impact of Delay in Adjuvant Treatment on Healthcare Resource Utilization and Cost Burden
BPI24-024: Evaluating and Improving Post-Operative VTE Prophylaxis in Patients With a History of Cancer: Results of a Quality Improvement Initiative in a Community Hospital Setting
BPI24-025: Prostate Biopsies Against Medical Advice: Unveiling New Biomarker Insights for Men
BPI24-026: Utilization of ExoDx Prostate Test for Prostate Cancer Risk Stratification in the African American Population
BPI24-028: A Best Evidence–Based Practice of Management of Pruritus to Anti–PD-1/PD-L1 Therapy
BPI24-200: Delays in Adjuvant Therapy in Head and Neck Cancers: Identifying Population Disparities and Implementing Solutions
Bioinformatics/Information Technology Sciences
Case Reports
CRE24-033: Complete Remission of Microsatellite Instability–High (MSI-H) Oligometastatic Poorly Differentiated Colon Adenocarcinoma After a Single Dose of Immunotherapy
CRE24-034: Successful Management of Locally Advanced and Oligometastatic Urothelial Carcinoma With Pembrolizumab-Based Induction Regimen Followed by Consolidative Radical Resection of the Primary Tumor: A Multi-Institutional Case Series
CRE24-035: Pembrolizumab-Induced Hemophagocytic Lymphohistiocytosis in a Patient With Breast Cancer: A Case Report and Systematic Review of the Literature
CRE24-036: Liver-ing on a Prayer: A Rare Case of Hepatocellular Carcinoma With Metastasis to the Thyroid
CRE24-037: Navigating the Challenges of NUT Midline Carcinoma: A Case Study and Therapeutic Insights for an Aggressive Oncologic Enigma
CRE24-038: Neuroendocrine Tumor of the Gallbladder: A Case Report and Literature Review.
CRE24-039: Preoperative Assessment of Vulvar Melanoma Surgical Margins Using In Vivo RCM
CRE24-040: Gluteal Metastasis of Intrahepatic Cholangiocarcinoma: Clinical Case and Literature Review
CRE24-041: Immunotherapy in Older Patients With Breast Cancer: Case Study and Literature Review
CRE24-042: Microgranular Acute Promyelocytic Leukemia Presenting as Recurrent Stroke and Isolated Neutropenia
CRE24-043: Effects of Web-Based Interventions on Quality of Life Among Patients With Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
CRE24-044: Response to Dabrafenib and Trametinib in a Patient With an Uncommon Activating BRAF Mutation: A First in Metastatic Non–Small Cell Lung Cancer
CRE24-046: Social Determinants of Health in Real-World Evidence Studies of Early-Stage Cancer Care: A Systematic Literature Review
CRE24-047: A Rare Case of Immune Checkpoint Inhibitor Induced Seronegative Myasthenia Gravis
CRE24-048: Unmasking the Unpredictable: Spontaneous Tumor Lysis Syndrome in Metastatic Breast Cancer—A Case Beyond Expectations
CRE24-049: Extrapulmonary Small Cell Carcinoma of Gallbladder Presenting as Acute Cholecystitis
CRE24-050: Microangiopathic Hemolytic Anemia as the Presenting Manifestation of Metastatic Breast Cancer
CRE24-051: Rare Case of a Paraneoplastic Cerebellar Ataxia Secondary to a Retroperitoneal Neuroendocrine Tumor of Unknown Origin
CRE24-052: Hyperfibrinolysis as the Primary Presenting Sign of Metastatic Prostate Cancer: A Diagnostic Challenge
CRE24-053: Brown Fat Adipose Tissue (BAT) Activation Mimicking Lymphoma-Associated Lymphadenopathy
Clinical Oncology
CLO24-057: Characterization of Short-Term Surgical Outcomes in Laparoscopic Gastrectomy at a High-Volume Center in Latin America: 10 Years of Experience
CLO24-059: The Impact of Proton Pump Inhibitors on Palbociclib in Advanced Breast Cancer Patients: A Systematic Review and Meta-Analysis
CLO24-060: Organomegalies as a Predictive Indicator of Leukemia Cutis in the Patients With Acute Myeloid Leukemia
CLO24-061: Overall Survival (OS) Impact for NSCLC Patients With irAE and Non-irAE Hospital Admissions During First-Line Pembrolizumab Treatment
CLO24-062: Aneuploid Epcam + Disseminated Tumor Cells (DTCs) Correlated With Liver Metastasis and Independently Predict Poor Survival in Small Cell Lung Cancer
CLO24-064: Evaluation of the Reliability of mpMRI in Diagnosing Prostate Cancer Following Intravesical Bacillus Calmette Guerin Therapy for Bladder Cancer
CLO24-065: Administration of Goserelin at Alternative Anatomical Sites in Premenopausal Breast Cancer
CLO24-066: Cemiplimab Use in Advanced Cutaneous Squamous Cell Carcinoma and Non–Small Cell Lung Cancer: Risk Factors Associated With Mortality
CLO24-067: Evaluating Kaposi Sarcoma in Kidney Transplant Patients: A Systematic Review and Meta-Analysis.
CLO24-068: The Role of Obesity in Influencing Patient Survival in Metastatic Renal Cell Carcinoma Patients Receiving Immunotherapy: A Systematic Review and Meta-Analysis.
CLO24-069: Pneumonitis Incidences in Metastatic Non–Small Cell Lung Cancer on Immunotherapy: A Systematic Review and Meta-Analysis
CLO24-070: Partial Versus Radical Nephrectomy: An Age-Wise Comparison of the National Cancer Database
CLO24-071: A Propensity Matched Survival Analysis Comparing Partial Versus Radical Nephrectomy in Patients with Metastatic Renal Cell Carcinoma: A National Cancer Database Study
CLO24-072: Length of Hospital Stay, Unplanned Readmission and Mortality for Patients Treated With Partial Nephrectomy or Radical Nephrectomy for Stage I and II Kidney Tumors
CLO24-073: Contemporary Treatment Patterns for Patients Diagnosed With cT1a Renal Tumors: A National Cancer Database Study
CLO24-074: Impact of Neoadjuvant Chemotherapy on Survival and Pathological Response Among Octogenarians Who Underwent Radical Cystectomy for Muscle-Invasive Bladder Cancer
CLO24-075: Surgeon Administered Transversus Abdominis Plane Block With Local Anesthetic Infiltration Versus Transversus Abdominis Plane Block Following Robot-Assisted Radical Prostatectomy
CLO24-076: Prolonged Anesthesia as a Risk Factor for Extended Length of Stay Following Craniotomy for Primary Glioma
CLO24-077: Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in the Era of Immunotherapy: An Analysis of the National Cancer Database (NCDB)
CLO24-079: Results From Phase 3 Trial of Imetelstat, a First-in-Class Telomerase Inhibitor, in Patients With Red Blood Cell Transfusion Dependent (RBC-TD) Non-del(5q) Lower-Risk Myelodysplastic Syndromes (LR-MDS) Relapsed/Refractory to/Ineligible for Erythropoiesis Stimulating Agents (ESAs)
CLO24-080: Association Between Primary Tumor Size and Prognosis in De Novo Metastatic Renal Cell Carcinoma in Patients Who Underwent First Line Immunotherapy-Based Therapy: Real World Data Analysis
CLO24-081: Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of Head and Neck–Biweekly Docetaxel, Cisplatin, 5-Fluorouracil, Leucovorin (TPFL) Versus Triweekly TPF: Response Assessment and Translation Into Survival Benefit
CLO24-082: A National Cancer Data Base (NCDB) Analysis of Prognostic Factors in Metastatic Triple-Negative Breast Cancer (TNBC)
CLO24-083: Efficacy of Selinexor in Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis
CLO24-084: Myeloid Sarcoma in a Patient With Marfan Syndrome
CLO24-085: Precision Medicine Drivers in Non–Small Cell Lung Cancer Brain Metastases
CLO24-086: The Effect of TBI-Based Conditioning Regimen on Recurrence and Transplant-Related Mortality Among Patients With Mantle Cell Lymphoma Who Received Autologous Bone Marrow Transplant
CLO24-088: Efficacy of Fruquintinib in Less Heavily Pretreated Patients (Pts) With Metastatic Colorectal Cancer (mCRC): Profile-Matched Data From FRESCO and FRESCO-2
CLO24-090: Demographics and Outcomes of Autologous Stem Cell Transplant Among IgD Multiple Myeloma Patients
CLO24-092: Neoadjuvant Tyrosine Kinase Inhibitors (TKIs) Efficacy in EGFR Positive Stage III Non–Small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis
Correlative/Genomic
Epidemiology/Risks/Prevention
EPR24-098: Epidemiological and Survival Analysis of Hemangiosarcoma in the Last Twenty Years
EPR24-099: Clinical and Epidemiological Characterization of the Oncologic Population in a Third Level Hospital in Northeastern Mexico
EPR24-100: A Comparison of Somatic Mutations and ELN Classification in De Novo Acute Myeloid Leukemia Between Appalachian and Non-Appalachian Kentucky
EPR24-101: Characteristics of Individuals With Early-Onset GI Cancers in the Southeastern US
EPR24-102: Determining the Barriers to Colonoscopy in Patients With Positive Cologuard Test
EPR24-103: Casting Light on Metastatic Kidney Cancer Survival: A Gender-Based Examination
EPR24-104: Re-Evaluating Breast Cancer Screening Recommendations: An Analysis of Breast Cancer Incidence by Age Groups
EPR24-105: Unveiling the Socioeconomic Gradient: Income-Linked Trends in Metastatic Kidney Cancer Survival
EPR24-106: Sociodemographic Trends and Regional Disparities Associated With Leukemia in Florida: Implications of an Aging-Population on Leukemia Incidences and Mortalities in the United States
EPR24-107: Disparities in Colorectal Cancer Mortality Outcomes: A Ten-Year Trend Study
EPR24-109: Intentional Weight Loss and Associated Cancer Incidence Among Patients With Overweight or Obesity: A Systematic Literature Review
EPR24-110: Prior SARS-CoV-2 in Patients With CAR-T Negatively Impacts Overall Survival, Highlighting the Need for Targeted Prophylaxis Strategies
EPR24-111: The Clinical Effect of a Community-Based Genetic Testing Program
EPR24-113: The Role of Social Determinants of Health in Gastrointestinal Cancer Outcomes in the United States Context: A Systematic Review
EPR24-114: Analysis of Risk of Bone Fracture and Osteoporosis and Dual-Energy X-Ray Absorptiometry Screening Rates in Lung Cancer Survivors With and Without Bone Metastases
EPR24-115: Evaluation of Framework for Colorectal Cancer Health Needs Assessment in North and Central Asian Countries
EPR24-116: Improving Anal Cancer Screening: A Comparative Analysis of High-Risk Human Papillomavirus Tests, Alone or in Combination With Anal Cytology Assays, to Predict High-Grade Squamous Intraepithelial Lesions
EPR24-117: A Comprehensive Examination of Disparities in Metastatic Breast Cancer Incidence: Race, Income and Geography
EPR24-119: Development of Heart Failure Following Anthracycline Exposure in Survivors of Adolescent and Young Adult Cancer in an Integrated Healthcare System
EPR24-120: A Data-Driven Approach to Increase Lung Cancer Screening Rate in the Catchment Area of an NCI-Designated Cancer Center via Community Outreach and Engagement
EPR24-121: Trends in the Incidence and Mortality of Metastatic Epidural Spinal Cord Compression: A Ten-Year Population-Based Study
EPR24-122: Mesothelioma: Trends in Palliative Care Utilization in Hospitalized Patients, a National Inpatient Sample (NIS) Study (2016–2020)
Outcomes and Health Services Research
HSR24-123: High Dose Rate Interstitial Brachytherapy for Squamous Cell Carcinoma of the Vagina: Methods and Outcomes at a Single Institution
HSR24-124: Determinants of Quality of Life and Optimism in Patients With EGFR Mutated Advanced Non–Small Cell Lung Cancer
HSR24-125: A Narrative Review on Geriatric Assessment and Outcomes in Diffuse Large B-Cell Lymphoma: Differentiating Fit, Frail, and Unfit Patients
HSR24-126: “Share the Fear”: Communication Concerns of Parents With Cancer With Dependent Children for Their Co-Parent: A Qualitative Study
HSR24-127: Rectal Cancer Disparities in Age and Overall Survival Among American Indian and Alaska Native Vs Non-Hispanic White Populations
HSR24-128: Real-World Treatment Patterns and Effectiveness of Selpercatinib in Patients With Locally Advanced/Metastatic Non–Small Cell Lung Cancer in the US
HSR24-129: Impact of Socioeconomic Status on Cancer Care in Southeast Texas: A Population-Based Cohort Study
HSR24-130: Real-World Outcomes in Patients With Burkitt Lymphoma in a Safety-Net Health System
HSR24-131: Patient Experiences and Perceptions of Biomarker Testing in AML and CML: A Qualitative Analysis
HSR24-132: Value of Early Transfusion Burden Reduction in Lower-Risk Myelodysplastic Syndromes (LR-MDS)
HSR24-133: Real-World (RW) Effectiveness of Erythropoiesis-Stimulating Agents (ESAs) After Luspatercept in Patients (pts) With Myelodysplastic Syndromes (MDS): A Retrospective Analysis of a Large Healthcare Claims Database in the United States
HSR24-134: Perceptions of CARTITUDE-4 for Patients With Relapsed/Refractory Multiple Myeloma
HSR24-135: Community Oncologists’ Perceptions on the Evolving Role of Surrogate Endpoints in Oncologic Clinical Trials
HSR24-136: The Impact of Prescription Drug Plan (Part D) Enrollment for Medicare Beneficiaries on Eligibility for Episodic Value-Based Care Model Participation and Total Cost of Care (TCOC) at a Community Oncology Network
HSR24-137: Does Routine Clinical Assessment of Older Adults With Gastroesophageal Cancer Tell the Whole Story?
HSR24-138: Real-World Treatment (tx) Patterns and Outcomes for First-Line (1L) Novel Hormonal Agent (NHA) Naïve Metastatic Castration Resistant Prostate Cancer (mCRPC) Including in Black and/or African American (BAA) Patients (Pts)
HSR24-139: Patient-Reported Outcome Measures Used in Patients With Chronic Phase–Chronic Myeloid Leukemia: A Systematic Review of the Literature
HSR24-140: A Mindfulness-Based Intervention for Caregivers of Autologous Hematopoietic Stem Cell Transplant Patients: Pilot Study Results
HSR24-141: Personalizing the Patient Experience: Understanding the Emotional State and Learning Preferences of Pancreatic Cancer Patients Receiving Multidisciplinary Care
HSR24-142: Real-World Clinical Benefit Among Patients (pts) With Lower-Risk Myelodysplastic Syndromes (LR-MDS) Treated With Luspatercept
HSR24-143: Impact of Frailty on Hospital Outcomes Among Patients With Hemophagocytic Lymphohistiocytosis Who Received Autologous Stem Cell Transplantation in the United States
HSR24-144: Does Immunotherapy Work in Patients With Poor Performance Status?
HSR24-145: Prevalence of Anxiety and Depression in Newly-Diagnosed Breast Cancer Patients in Rural Minnesota
HSR24-146: Chemotherapy-Induced Febrile Neutropenia (FN) in the US: Healthcare Resource Utilization (HCRU) and Costs
HSR24-147: Non-Optimal Treatment in Early-Line Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated With Tyrosine Kinase Inhibitors (TKI): A Claims Data Analysis
HSR24-148: Outcome of Positron Emission Tomography–Computed Tomography Staging in Breast Cancer Patients Having Neo-Adjuvant Systemic Therapy
HSR24-149: Mobile Health (mHealth) Interventions for Colorectal Cancer (CRC) Survivors: A Systematic Review
HSR24-150: Real-World Treatment Patterns of Selumetinib Among Patients With Neurofibromatosis Type I and Plexiform Neurofibroma in the United States
HSR24-152: Patient-Reported Outcome (PRO) Data in Oncology NDAs Approved by the FDA (2018–2021): A Review of Criticism and Concerns in Comments From Regulators
HSR24-153: Real-World Clinical Outcomes of First-Line Therapies and Treatment Regimens for BRAF-Mutant Advanced/Metastatic Melanoma: Retrospective Observational Study
HSR24-154: Real-World Clinical Outcomes in Patients With Advanced/Metastatic Melanoma and Brain Metastases Treated With Pembrolizumab Monotherapy—An Analysis of the ADOReg German Skin Cancer Registry
HSR24-155: Disparities in Real-World Screening Mammography Compliance Rates by Body Mass Index and Mobility-Restricting Diagnosis—A Commercial Claims-Based Analysis
HSR24-156: Treatment Patterns and Blood Count Control in 10,112 Patients With Polycythemia Vera Managed at Community Practices in the United States
HSR24-157: Standalone Performance Evaluation of an Artificial Intelligence Breast Cancer Detection Tool on Consecutively Collected Biopsy Proven Breast Cancer and Screening Negative Tomosynthesis Cases
HSR24-158: Working and Cancer: The Impact of Cancer Diagnosis and Treatment on Employment, Presenteeism, and Productivity
HSR24-159: Relationship Between Durable Transfusion Independence (TI) and Survival Outcomes in Patients (Pts) With Lower-Risk Myelodysplastic Syndrome (LR-MDS): An Analysis From US Health Insurance Claims Data
HSR24-160: Immune Checkpoint Inhibitor-Induced Type 1 Diabetes Mellitus: Patient Characteristics, Clinical Outcomes, and Survival Implications of Autoantibodies
HSR24-161: Biomarker Testing, Surgical Outcomes, and Adjuvant Therapy Rates Among Patients With Resected Non–Small Cell Lung Cancer (NSCLC) in the Community Setting in the United States (US), 2019–2023
HSR24-162: Treatment Patterns in Surgically Resected NSCLC Since the Introduction of Immuno-Oncology Agents
HSR24-163: Comparative Assessment of Social Determinants of Health in Community and Academic Hospitals for Patients Diagnosed With Hepatocellular Carcinoma
HSR24-164: Predicting Treatment-Related Fatigue in the Context of Lymphoma and Chronic Lymphocytic Leukemia
HSR24-165: Educational Efficacy of YouTube Videos on Multiple Myeloma
HSR24-166: Implementation of an Integrated Supportive Care Medicine Consultation Service Within a Gastrointestinal Cancer Clinic: Timeliness of Referrals and Patient Access
HSR24-167: Improved Access Through an Integrated Supportive Care Model Reduced Urgent Care Referral and Admission Rates for Patients With Gastrointestinal Malignancy
HSR24-168: The Impact of the COVID-19 Pandemic on Cancer Treatments: A SEER Population Based-Analysis
HSR24-169: Autonomic Symptoms May Suggest Paraneoplastic Neurological Syndromes in Small Cell Lung Cancer
HSR24-170: Utilization of Biomarker Testing and Biomarker-Driven Targeted Therapy Among Patients With Metastatic Non–Small Cell Lung Cancer
HSR24-171: Utilizing Diverse Enrollment to Validate the DELFI Fragmentome Test for Advancing Lung Cancer Screening
HSR24-172: Comparing Apples to Apples in Uterine Cancer: Racial Disparity and Propensity Score Matching
HSR24-173: Reaching Unmet Needs of Lung Cancer Patients Through Hope Totes and Educational Meetings
HSR24-174: Underserved Patients Find Their Voice Through Newly Formed SCLC Community
Quality Improvement
QIM24-176: Technology’s Impact on Implementing the NCCN Distress Thermometer in a Community-Based Oncology Clinic
QIM24-178: Managing Pharmaceutical Costs in the Oncology Care Model
QIM24-179: Instituting Quality Improvement Processes With Periprocedural Heparin Infusions at a Major Cancer Center Utilizing a Failure Mode and Effects Analysis
QIM24-180: Implementation of an USG Peripheral IV Placement Program
QIM24-181: Joining Forces to Minimize Hypomagnesemia in Patients Receiving Cisplatin and Cetuximab Infusions
QIM24-182: Retrospective Analysis of 30-Day Readmission Risk in Oncology Patients
QIM24-183: Novel Therapies in the Oncology Care Model: A Profile in Review.
QIM24-184: Monitoring Concordance of Chronic Lymphocytic Leukemia (CLL) at Watson Clinic LLP: Diagnosis & Treatment
QIM24-185: Reimagining the Pathology Report: Virtual 3D Specimen Mapping in Oncologic Surgery
QIM24-186: Surviving and Thriving After Lung Cancer: A Pilot Project to Understand Physician Perspectives on the Approach to Lung Cancer Survivorship Care at Weill Cornell Medicine Medical Oncology
QIM24-187: Determining the Most Appropriate FIT to Increasing Colorectal Cancer Screening in the Community
QIM24-188: Compliance With Recommendations and Clinical Practices Increased After Publication of the Japanese Clinical Practice Guidelines for Pancreatic Cancer 2022 Edition
QIM24-189: Molecular Tumor Boards Excellence. Phase 1—State of the Art in Spain
QIM24-190: A Safety Net System for Significant Diagnostic Imaging Actionable Findings at a Comprehensive Cancer Care Center
QIM24-191: Standardizing Height and Weight Measurement for Treatment Calculations in Adult Patients With Cancer
QIM24-192: Place of Death From Cancer in Episodic Value Based Care Models in a Community Oncology Network
QIM24-193: Development and Pilot Testing of a Comprehensive Set of Measures for Organizational Assessment of NCCN Guideline Recommended Genomic Testing
QIM24-194: A Cost Effective, Noninvasive Mutiomics Assay (BCDx) for Diagnostic Accuracy of Bladder Cancer Compares to the Gold Standard of Cytoscopy and Cytology
Trials in Progress
  • Collapse
  • Expand